Therapy Resistance and CSCs

A major challenge in cancer treatment is the ability of CSCs to resist chemotherapy and radiation. This research track investigates the mechanisms behind this resistance, focusing on CSCs' ability to remain in a quiescent state, enhancing their DNA repair capabilities and activating drug efflux pumps to remove chemotherapeutic agents. Additionally, CSCs' high expression of survival pathways and anti-apoptotic proteins makes them less susceptible to conventional treatments. This track explores how these intrinsic properties of CSCs contribute to disease recurrence and poor patient prognosis. The aim is to discover novel therapeutic approaches that target these resistance mechanisms, ensuring that CSCs are eradicated alongside the bulk tumor cells, thereby preventing relapse and metastasis.

    Related Conference of Therapy Resistance and CSCs

    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    December 12-13, 2024

    44th Euro Congress on Cancer Science & Therapy

    Rome, Italy
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands

    Therapy Resistance and CSCs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in